Carter's Q1 Earnings Beat Estimates, Stock Down on Paused Guidance

In This Article:

Carter's, Inc. CRI announced its first-quarter 2025 results, wherein the top and bottom lines beat the Zacks Consensus Estimate. However, on a year-over-year basis, the company’s sales and earnings declined.

Carter’s shares plummeted more than 10% on Friday after the company reported weak first-quarter 2025 results and announced the suspension of its financial guidance. This decline was also attributed to the recent CEO transition, as the new leadership team is likely to take time to fully assess the business and establish a strategic path for sustainable growth.

In addition, the current tariff environment has introduced significant uncertainty, making it difficult to predict the company’s future financial performance. As a result, Carter’s has decided to suspend providing guidance until there is more clarity on the internal operational direction and external market conditions.

Carter’s adjusted earnings per share (EPS) of 66 cents per share surpassed the Zacks Consensus Estimate of 53 cents per share. However, the bottom line fell 36.5% from $1.04 reported in the prior-year quarter. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)

Carter's, Inc. Price, Consensus and EPS Surprise

Carter's, Inc. Price, Consensus and EPS Surprise
Carter's, Inc. Price, Consensus and EPS Surprise

Carter's, Inc. price-consensus-eps-surprise-chart | Carter's, Inc. Quote

The company reported consolidated net sales of $629.8 million, which beat the Zacks Consensus Estimate of $621 million. The metric declined 4.8% from $661.5 million posted in the year-ago period. The decline was due to macroeconomic pressures, including inflation, elevated interest rates and weakening consumer confidence, which reduced demand across segments. Additionally, unfavorable foreign currency translation impacted consolidated net sales by approximately $6.4 million, or 1.0%.

Shares of this Zacks Rank #5 (Strong Sell) company have lost 37.6% in the past three months compared with the industry’s 26.1% decline.

CRI Stock's Price Performance

Zacks Investment Research
Zacks Investment Research


Image Source: Zacks Investment Research

Insights Into CRI’s Segment

Sales of the U.S. Retail segment decreased 4.3% year over year to $294.4 million. The segment’s comparable net sales fell 5.2% in the first quarter. Our model predicted sales of $289.3 million for the segment.

The U.S. Wholesale segment’s sales fell 5.3% year over year to $250.1 million due to differences in the timing of shipments as compared to the last year. We expected net sales of $245.9 million for the segment.

The International segment witnessed a 4.9% year-over-year drop in sales to $85.3 million. We expected net sales of $86.1 million for the segment.